{"id":"W2409115721","doi":"10.1016/j.jval.2015.09.1199","title":"Cost-Effectiveness Of Ceritinib In Previously Treated Patients With Crizotinib In Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Medicine; Ceritinib; Pemetrexed; Internal medicine; Oncology; Lung cancer; Population; Anaplastic large-cell lymphoma; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005521231,0.0003419899,0.0008447056,0.0006517587,0.0008226685,0.001737809,0.001095074,0.0007392745,0.001852439],"category_scores_gemma":[0.003315018,0.0002386684,0.001728881,0.00172606,0.0005309421,0.0004248767,0.0004644291,0.001021674,0.00009930185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07476608,"about_ca_system_score_gemma":0.04310881,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9676779,"about_ca_topic_score_gemma":0.9817823,"domain_scores_codex":[0.998985,0.0001548462,0.00009470473,0.0001234332,0.0002822657,0.0003597386],"domain_scores_gemma":[0.9979686,0.0002384348,0.0004596242,0.00002247313,0.0003579907,0.0009529635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01802154,0.001013786,0.8039168,0.001280143,0.003812589,0.001765944,0.0004474105,0.02955023,0.001548484,0.002945768,0.0208238,0.1148734],"study_design_scores_gemma":[0.002495649,0.001803828,0.9630448,0.0004073793,0.002298255,0.0009403218,0.001051657,0.01893012,0.0005009552,0.0004968276,0.007922011,0.0001082306],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9705974,0.01395465,0.0001302654,0.005807752,0.0001155014,0.00009019343,0.003933527,0.00002527045,0.005345443],"genre_scores_gemma":[0.9956105,0.002357197,0.00009631251,0.0003153903,0.00003942282,0.00001245682,0.0009740628,0.000004678561,0.0005898391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07476608,"threshold_uncertainty_score":0.5424684,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02534956504049127,"score_gpt":0.3133472650491722,"score_spread":0.2879977000086809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}